Asbestos & Mesothelioma Studies

Threat of mesothelioma a lifetime fear

Developing mesothelioma after asbestos exposure is a known occurrence, yet little research is conducted to evaluate the risk period after first exposure. Scientists in Italy and Australia studied more than 20,000 people exposed to asbestos and more than 800 patients diagnosed with mesothelioma to determine the long-term risks. Based on[…]

Read More »

Firefighters at higher risk for many cancers including mesothelioma

When the alarm sounds, they don’t think about the dangers ahead or their possible loss of life. Firefighters immediately react, placing the lives of those in peril ahead of their own. They charge into burning buildings with one goal in mind, not pausing to consider the longterm effects. Unfortunately for[…]

Read More »

Mesothelioma may have a new cause

Researchers in China found a substance that may lead to mesothelioma. Developed to resist chemicals, multi-walled carbon nanotubes (MWCNTs) are used in textiles, manufacturing, electronics and optics. Like asbestos, the MWCNTs may cause mesothelioma when inhaled. Rats at the Anhui Medical University College of Basic Medial Sciences were exposed to[…]

Read More »

Mesothelioma treatments found in unlikely places

Scientists around the world work endlessly to discover new treatments for mesothelioma. Taking decades to develop, the asbestos-caused cancer leaves most with less than a year to live after diagnosis. Many studies focus on the effectiveness of current treatments, hoping to expand current knowledge and provide victims with the best[…]

Read More »

Asbestos, a known killer, continues to wreak havoc with no end in sight

Imagine a group of murderers, terrorizing the world under the guise of protecting our safety. After thousands of unnecessary deaths, someone finally stands up to the killers and sends all but one to jail. Why leave this one free? Certain people claim he’s less dangerous than his associates. He really[…]

Read More »

New research suggests earlier mesothelioma diagnosis is a possibility

Those familiar with the asbestos-caused cancer mesothelioma are well aware the disease takes decades to develop and by the time it’s recognized, it’s too late for recovery.  When symptoms finally develop and mesothelioma is diagnosed, its victims often survive less than one year. In 2008, Japanese researchers released a study[…]

Read More »

New study suggests breast cancer drug may shrink mesothelioma tumors

After new evidence surfaced suggesting the enzyme aromatase is associated with malignant mesothelioma, Italian scientists began testing breast cancer drug Aromasin (exemestane) on mice and mesothelioma cells. Designed to inhibit aromatase, Aromasin curbs cell growth in breast cancer patients by helping reduce the amount of estrogen in the body. In[…]

Read More »

Alimta remains best treatment for victims of malignant pleural mesothelioma

For those with inoperable malignant pleural mesothelioma, Alimta (permetrexed) combined with cisplatin remains the top treatment. Japanese researchers recently analyzed the results of 30 patients taking either Gemzar or the Alimta combination and compared complications, disease control and survival rates. Thirty mesothelioma cases were examined featuring 13 patients taking Gemzar[…]

Read More »